NCT06210607View on ClinicalTrials.gov

A Trial of HS-10511 in Healthy Subjects

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
Hypertrophic Cardiomyopathy
Interventions
DRUG

HS-10511 Tablets

HS-10511 tablets for 5\~6 SAD cohorts and 4 MAD cohorts

DRUG

HS-10511 Tablets Placebo

HS-10511 tablets placebo for 5\~6 SAD cohorts and 4 MAD cohorts

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY